The pro-invasive effects may arise from transfer of oncogenic signaling molecules from glioma cells to adjacent astrocytes via Cx43 (Figure 1, Pathway 1), followed by spread of these signals (and/or their downstream effectors) among astrocytes through astrocyte–astrocyte GJs (Figure 1, Pathway 5). The gene discussed is GJA1; the disease is central nervous system cancer.